Richard Kent Joins Intersouth Partners
Richard Kent has joined Intersouth Partners as a venture partner focused on the pharmaceutical market. He previously was president and CEO of Serenex Inc., an Intersouth portfolio company sold to Pfizer in April.
9 December 2008•3 mins read
